SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-018834
Filing Date
2023-05-18
Accepted
2023-05-18 06:07:35
Documents
10
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 6-K q1236-kcover.htm 6-K 17126
2 EX-99.1 q123financialstatements.htm EX-99.1 880512
3 EX-99.2 q123mda.htm EX-99.2 790701
4 EX-99.3 q123ceocertification.htm EX-99.3 9229
5 EX-99.4 q123cfocertification.htm EX-99.4 9314
6 EX-99.5 q123earningsrelease.htm EX-99.5 304508
7 EX-99.6 q123form5.htm EX-99.6 71037
8 image_01.jpg GRAPHIC 8736
9 image_01a.jpg GRAPHIC 31313
10 image_0a.jpg GRAPHIC 32432
  Complete submission text file 0001628280-23-018834.txt   2183657
Mailing Address 610 - 700 WEST PENDER STREET VANCOUVER A1 V6C 1G8
Business Address 610 - 700 WEST PENDER STREET VANCOUVER A1 V6C 1G8 604-218-4766
Curaleaf Holdings, Inc. (Filer) CIK: 0001756770 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-249081 | Film No.: 23933647
SIC: 2833 Medicinal Chemicals & Botanical Products